Introduction
Cerebral palsy (CP) describes a group of developmental disorders of movement and posture causing activity restriction or disability, which are attributed to disturbances occurring in the fetal or infant brain [1] . CP constitutes the most common cause of chronic childhood disability, with rates estimated to be between 2 and 2.5 per 1000 live births [2] . The hallmark of CP is abnormal muscle tone of which spasticity is the most common type, accompanied by loss of selective motor control and impaired balance [3] . As muscles grow in response to the stimulus of stretch, muscle contractures due to hypertonia that are initially dynamic become fixed as tight muscles fail to grow proportionately with the bones that they traverse [4] . These abnormal forces on the growing skeleton lead to secondary bony deformities and joint instability (lever arm dysfunction) [5] . The interaction of joint contractures, muscle weakness, bony deformities and joint instability occurring at multiple levels affects the quality and efficiency of gait and other aspects of physical function of ambulatory children with CP.
The primary goal of treatment of these children is to preserve or improve present and future function and secondarily to improve the appearance of gait [6] . This is accomplished by the prevention or correction of joint contractures and skeletal deformities. A number of complementary strategies are used either sequentially or in combination, including physical therapy, orthotics (braces), serial casting, tone reduction by pharmacologic or neurosurgical methods, and orthopaedic surgery, which includes tendon lengthening or tendon transfers and corrective osteotomies. When joint contractures and bony deformities occur at multiple levels, these are best addressed with simultaneous multilevel orthopaedic surgery [7] [8] [9] .
Gait analysis is often used in the assessment of children with ambulatory CP to refine clinical decision making. The purpose of this article is to review the role of gait analysis in the orthopaedic management of children with ambulatory CP and to examine the current evidence to support these roles.
Gait assessment of ambulatory children with cerebral palsy
The physical examination of an ambulatory child with CP includes an assessment of hypertonia, joint range of motion, muscle strength, skeletal alignment and observation of the child walking. The visual assessment of walking may be augmented by videotaping with the use of slow-motion and split-screens to view the child's gait simultaneously from the front, back and side. In many centres, patients also undergo three-dimensional gait assessment in a motion laboratory. The typical laboratory uses multiple high-speed motion cameras to capture the range of joint motion (kinematics) occurring in the sagittal, coronal and transverse planes over the entire gait cycle. The subject walks on force plates embedded in the floor, which calculates the joint moments and power (kinetics). Kinematic and kinetic data are presented as waveforms over the entire gait cycle, along with the typical waveforms of normal gait for comparison. Subjects may also undergo dynamic electromyography (EMG) to record the timing of activation of specific muscles/muscle groups during the gait cycle and measurement of energy expenditure or oxygen consumption during walking [10] .
The data generated from the gait analyses are used to quantify the magnitude of deviation of gait from normal and, in combination with the physical examination and visual assessment of the gait, help to provide a qualitative explanation for these deviations. These data are used collectively to guide the choice of interventions to optimize gait efficiency and quality.
Value of gait analysis
Gait analysis provides an objective record of gait and has played an indispensable role in refining the understanding of pathologic gait in CP [11, 12] , and continues to do so [13] . The recognition of specific patterns has allowed gait pathology to be classified, which assists in diagnosis, communication and clinical decision making [14] . The reliability, validity and the clinical utility of these gait characterizations have not been well established, however [15] . The use of gait analysis before and after interventions allows us to study the effects of specific interventions on these gait patterns [16, 17] . Also, in the context of outcomes research, gait analysis is a useful objective measure of gait outcomes, even if these are, at best, an as yet unproven proxy for the more meaningful outcomes for this population, namely actual physical function and participation in day-to-day physical activities [18] .
Gait analysis: the controversy
While gait laboratory analysis is accepted as an important research tool, there is much controversy about its clinical utility in routine decision making for the surgical management of this population. The magnitude of the controversy is best captured in back-to-back editorials by Gage [11] and Watts [19] , respectively, in the Journal of Paediatric Orthopaedics. Gage opines that gait analysis has made tremendous contributions to the understanding of pathological gait in CP. Gait analysis provides an objective record, quantifies various gait parameters and can sort out the complex interactions of multiple abnormalities and their impact on gait [11] . Advocates of gait analysis also believe that this information is essential to decide which surgical procedures are indicated [11, 20, 21] . On the other hand, Watts believes that gait analysis is useful only to compare changes before and after therapeutic interventions [19] . Detractors of gait analysis feel that the motion laboratory is not an optimal setting to evaluate a child's gait, and that gait analysis is an expensive evaluation that has no proven clinical benefits and should remain a research tool [19, 22] . Furthermore, children with CP have been shown to have significant (intra-subject) variability in their gait [23, 24] . Interpretation of gait analysis data is also subject to considerable variability, even among experts, giving rise to variability in decision making [25] . It has also been shown that gait analyses of the same patients tested at different gait laboratories may not produce concordant results, and which may also lead to different recommendations [26] . This latter study has fuelled the controversy further, with no resolution about the value of gait analysis in sight [27, 28] . Still others recommend an intermediate position, advocating gait analysis under certain circumstances, where it is available [9] . No accepted guidelines exist as to when such an evaluation is indicated, however.
Consequently, there is wide variation across North America in the rates of utilization of gait analysis for surgical decision making in the management of children with ambulatory CP (Narayanan UG, unpublished data). It is not clear whether there is corresponding variation in functional outcomes of children receiving multilevel orthopaedic surgery in different centres in North America and, if so, whether these differences are attributable to the use of gait analysis or other factors, such as surgical skill and experience, or the quality of the postoperative rehabilitation, to name just two.
In the gait analysis debate, the fundamental question that needs to be answered is: Compared with observational gait analysis alone, does the addition of gait laboratory analysis for surgical decision making result in improved functional outcomes following multilevel lower extremity orthopaedic surgery in ambulatory children with spastic CP? For gait analysis to be effective in this role, it needs to be shown to alter decision making in a reproducible or consistent way, and that these decisions result in better outcomes.
Does gait analysis alter decision making?
The basic premise of gait analysis is that gait data generated in a motion laboratory provide insight beyond what is derivable from observational analysis alone, and have the potential to influence or alter treatment decisions for at least some patients.
The literature does show that gait analysis alters surgical decision making for patients with CP. In three separate studies [29] [30] [31] , treatment recommendations based on observation of gait changed with the addition of gait analysis data in 52, 93 and 40% of the cases, respectively. In all three studies, however, the investigators were not blinded to their decisions based on observation alone. We also do not know whether these decisions would have been consistent if retested at a later time (reproducibility). In the Hartford study [29] , all patients reportedly underwent treatment based on the gait analysis recommendations, and, therefore, in the absence of controls, we do not know whether implementing these recommendations did indeed result in different, let alone better, outcomes. DeLuca et al. [29] concluded that as, in their series, gait analysis data led to an overall reduction in the number of procedures recommended, this would be associated with a reduction in cost of surgery. We do not know whether the treatment decisions based on gait analysis were the ones that were in fact carried out, however. Furthermore, conclusions regarding potential cost reductions are somewhat speculative, as a valid health economic evaluation was not performed. Kay et al. [30] and Cook et al. [31] also demonstrated that decisions were altered by the addition of gait analysis data, but, once again, with little evidence that these altered decisions were either reproducible or better than the original decisions made by observation alone. Interestingly, the direction in which treatment recommendations were altered varied across all three studies, which leaves us wondering how reliable the actual decision-making process is.
Variability in gait analysis
Gait analysis comprises a battery of tests and ultimately is a measurement, much like blood pressure, EKG or radiographs, whether it is intended to influence decision making or is an outcome instrument to measure change. An absolute prerequisite of validity for any clinical measurement is reliability -the property of producing the same result when the patient is measured more than once, by one or more testers on one or more occasions, provided the patient has not clinically changed in the interval between the repeated measurements. In the presence of significant variability, the data cannot be used with confidence to influence decision making, nor can we assume that any recorded changes to a patient's gait are due to some clinical intervention and not due to the variability in recording these parameters. Unfortunately, there are many sources of variability stemming from gait analysis, including the patients themselves, the motion laboratories, data acquisition, data interpretation and recommendations thereof.
Patients have been shown to be one important source of variability, and intra-subject variability has been shown to be worse in children with CP [23, 24] . Variability between laboratories is attributable to the lab environment, hardware or software utilized. Variation in the way markers are applied is an important source of error, and the effects of skin marker motion have been well documented. Another threat to validity has been the lack of standardization of marker sets, number of segments defined, of coordinate systems and joint centre estimates, and normalization of data, to name a few.
Variability arising from lack of standardization is being addressed in collaborative efforts such as the one reported by Gorton et al. [32] , which was implemented across the 12 gait labs in the Shriner's system in North America. Following the implementation of the protocol, there was only a moderate decrease in the variability across the 12 sites, and significant differences remain that the authors concluded must be addressed before the data can be considered comparable [32] . These are technical problems, which, in time, are likely to be solved with technical solutions, which won't, however, address the issue of variability of interpretation and treatment recommendations.
Reproducibility of gait analysis interpretation and surgical recommendations
Skaggs et al. [25] sent gait analysis data from seven patients to 12 experienced gait lab clinicians -two in each of six institutions across the United States. Based on the data provided, the gait experts were asked to generate a list of gait problems and make treatment recommendations. Agreement among physicians for the most commonly diagnosed problems was slight to moderate at best (Kappa values: 0.14-0.46). Agreement about specific surgical recommendations was similarly poor, except for hamstring lengthening (Kappa: 0.64). The authors concluded that although gait analysis data are themselves objective, there is subjectivity in interpretation, even among recognized experts, with diagnoses and treatment recommendations seemingly influenced by the institution at which the interpretation was performed [25] . The authors did not report the inter-rater reliability at the institutional level, however, which would have provided some support to the latter conclusion.
The consequences of such variability were also illustrated by Noonan et al. [26] , who sent 11 ambulatory patients with spastic CP to four different centres for gait analyses. There was variability in the kinematic data generated across the four laboratories [26] , although the clinical significance of some of this variability has been challenged [28] . Nevertheless, the treatment recommendations were widely different across the four centres for nine of the 11 patients. Perhaps such variability might not have been demonstrated had the patients been tested in other gait centres, as was implied in the accompanying editorial [28] , but evidence to support this contention remains elusive.
Variability in the interpretation of gait data reflects the prevailing uncertainty (or controversies) about the causes or significance of specific findings, and will only be resolved with ongoing clinical research and experience using gait analysis. Similarly, variability in treatment recommendations based on the same gait data also reflects differences of opinion about best strategies to deal with specific problems, which, in turn, can only be definitively resolved with comparative clinical trials. Neither the variability in interpretation nor the variability in surgical recommendations is the fault of gait analysis per se, but as long as such significant variability exists, the case for routine gait analysis in preoperative decision making will be seriously undermined.
Does gait analysis for decision making result in better functional outcomes?
In a systematic review of the literature on the use of gait analysis in children with walking disorders, Haley and Tomie [33] found little published evidence that outcomes of surgery based on gait analysis are any better than outcomes of surgery based on observational analysis alone. They identified only one case-control study, which, to date, is the only study that attempts directly to answer this question. Lee et al. [34] retrospectively selected 23 patients with ambulatory CP who had complete preoperative and postoperative gait analysis available out of 100 patients who had been evaluated in their gait lab over a 5-year period. Eight of these 23 children underwent surgery based on the visual analysis alone rather than the recommendations based on gait analysis. The authors provided no information as to why these eight patients underwent operations different from what was recommended or whether their surgeons had had access to the gait studies. The gait outcomes of these eight children were compared with the outcomes of the 15 children who were treated according to the recommendations based on preoperative gait analysis. Using the postoperative gait analysis data as the outcome measure, seven children reportedly did not improve. Five of these seven belonged to the control group that received treatment based on clinical (visual) analysis alone. In other words, 13 of 15 children showed improved gait outcomes in the gait analysis group compared with only three of eight in the control group. The authors concluded that gait analysis was responsible for the difference in outcomes between the two groups. The small numbers of patients, the absence of information on the comparability of the two groups at base line, the short follow-up and the absence of any functional outcomes, however, undermine any conclusions regarding the necessity for, or the benefits of, preoperative gait analysis.
Other retrospective case series [18, 35, 36] of children with ambulatory CP undergoing multilevel orthopaedic surgery, in which patients underwent pre and postoperative gait analyses, have documented postoperative improvement in outcomes. In the absence of any controls, however, it is not possible to conclude with any confidence that these improvements are attributable to the use of gait analysis either.
Molenaers et al. [37 ] suggest that gait analysis delays the first orthopaedic procedures in children with CP based on a retrospective review of 424 children with ambulatory CP treated at one centre from 1985 to 2001. Three historical cohorts were compared: Group 1 (1985-89), Group 2 (1996-97) and Group 3 (2000-01), separated by the introduction of gait analysis in 1990, and the addition of botulinum toxin-A in the early treatment of these children in 1996. Children in Group 1, who did not have the benefit of gait analysis or botulinum toxin, underwent surgery significantly earlier than those in Group 2, who had the benefit of gait analysis. There was also a significant decrease in the frequency of surgery for Groups 2 and 3 compared with Group 1. The authors acknowledge the limitations of such a study and are careful to qualify their conclusions. The association between the introduction of gait analysis and the delay of surgery could be attributable to change in philosophy with the times rather than the introduction of gait analysis. Furthermore, delay of surgery is, at best, a proxy for, and not necessarily representative of, improved outcomes.
More recently, Chang et al.
[38 ] evaluated retrospectively 20 children with ambulatory CP who were recommended orthopaedic surgery after undergoing gait analysis. For reasons that are unclear, 10 children did not follow through with these recommendations and underwent unspecified alternative nonoperative treatments, while the other 10 completed the surgical procedures recommended. The surgical group experienced 'a higher percentage' of positive (44%) gait outcomes compared with the group who did not follow the gait analysis-based surgical recommendations (26%). The authors concluded that 'gait performance can be significantly improved when gait analysis is used to determine the appropriate surgical intervention'. Little information exists about the comparability of the two groups at baseline, however, other than the similarity of the surgical recommendations based on gait analysis. The 'outcomes' are based on desired or expected changes in the gait kinematics. This definition is unsatisfactory because all changes are arbitrarily treated as equal. We also have no knowledge of how these changes relate to the outcome of real interest, which is physical function. The only conclusion is that in this series, patients treated with surgery did better, based on the authors' definition of gait outcomes, than patients treated by the nonoperative methods. The actual contribution of gait analysis to these outcomes is speculative.
Gait analysis: health technology assessment and economic implications
Although there is scant evidence that functional outcomes are improved as a result of gait analysis, the use of clinical gait analysis has dramatically expanded in the last decade. Despite the availability of improved and cheaper measurement systems and software for the data collection and reporting, gait analysis remains expensive health technology. A motion analysis laboratory requires considerable capital investment of money and space, in addition to funding of trained personnel. Each test takes between 2 and 4 h to complete, and an additional 1-2 h of a therapist's or surgeon's time for data analysis and interpretation [39] . With spiralling healthcare costs and finite resources, the routine application of expensive health technologies cannot be justified until the evidence unequivocally demonstrates its utility [40, 41] . In many parts of the United States, gait analysis for clinical decision making is either insufficiently funded or not reimbursed at all by insurance companies or other payers (Narayanan UG, unpublished data). Similarly, gait analysis for routine clinical decision making is not funded by the provincial health insurance programmes in many parts of Canada (Narayanan UG, unpublished data). Payers might be willing to turn their attention from short-term savings to longterm predictable improvements in cost and quality that might arise from the appropriate use of technology, if these can be demonstrated [42, 43] .
Conclusion
Many paediatric orthopaedic surgeons have been reluctant to embrace this technology [39] . Gait analysis is complex, takes time to learn, and is expensive and time-consuming to practice. The layers of variability and the dearth of evidence that functional outcomes are improved as a result of gait analysis provide many with an all too easy justification to dismiss this technology. The gait analysis community has done a tremendous job in sharing the knowledge gained from their experience to educate those interested in learning about gait analysis, but have not yet succeeded in establishing that it reliably leads to better decisions and the performance of the 'correct' interventions, which, in turn, leads to better patient outcomes, at a cost that society and healthcare resources can bear. Until this evidence is established, many paediatric orthopaedic surgeons and funders of healthcare will remain resistant to the use and funding of gait analysis. The status quo will prevail, with wide area variation in the rates of utilization of gait analysis, and with ambulatory children with CP either being deprived of a useful assessment tool in many centres or being subjected to an unnecessary evaluation that is both expensive and time-consuming in others [44, 45] . The time is ripe for longitudinal comparative cohort studies and clinical trials to provide the evidence to resolve this controversy once and for all. Children in Group 1, who did not have the benefit of gait analysis or botulinum toxin, underwent surgery significantly earlier than those in Group 2, who had the benefit of gait analysis. The association between the introduction of gait analysis and the delay of surgery could be attributable to change in philosophy with the times rather than the introduction of gait analysis. Furthermore, delay of surgery is, at best, a proxy for, and not necessarily representative of, improved outcomes. Twenty children with ambulatory CP were recommended orthopaedic surgery after undergoing gait analysis. Ten children did not follow through with these recommendations and underwent unspecified alternative nonoperative treatments, while the other 10 completed the surgical procedures recommended. The surgical group experienced 'a higher percentage' of positive (44%) gait outcomes compared with the group that did not follow the gait analysis-based surgical recommendations (26%). The data are insufficient to support the authors' conclusion that 'gait performance can be significantly improved when gait analysis is used to determine the appropriate surgical intervention'. Little information exists about the comparability of the two groups at baseline other than the similarity of the surgical recommendations based on gait analysis. The 'outcomes' are based on desired or expected changes in the gait kinematics, but we have no knowledge of how these changes relate to physical function. In this retrospective case -control study, patients treated with surgery did better than patients treated by the nonoperative methods based on the authors' definition of gait outcomes. The actual contribution of gait analysis to these outcomes is speculative.
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